Correspondence on Letter regarding “Personalized Approaches to the Treatment of Hepatocellular Carcinoma Using Immune Checkpoint Inhibitors” |
Sun Young Yim1, Sung Hwan Lee2, Ji Hoon Kim1, Sunyoung S Lee3, Ahmed O Kaseb3, Ju-Seog Lee4 |
1Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea 2Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, CHA Bundang Medical Center, CHA University, Korea 3Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 4Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA |
|
Received: September 23, 2024 Revised: September 29, 2024 Accepted: October 2, 2024 |
|
|
|